Moderna’s COVID-19 Vaccine Is Making Good Progress but Valuation Is Too High, Says J.P. Morgan
Coronavirus pharma news roundup – 31/07/20
Exclusive: Chinese-backed hackers targeted COVID-19 vaccine firm Moderna
REITs For The Right Reason
CZI, CZ Biohub, and the State of California partner to track COVID-19 spread statewide
Coronavirus Lockdowns At What Price And At Whose Cost?
Re-engineering antibodies for COVID-19
Johnson & Johnson starts human study of Covid-19 vaccine
Single-shot COVID-19 vaccine protects non-human primates
Gold - The Sine Qua Non Investment
Bill Gates discusses the coronavirus death rate
Florida Smashes Record COVID-19 Death Tally For 3rd Straight Day As "Second Wave" Spreads In Europe, China: Live Updates
Florida Smashes Record COVID-19 Death Tally For 3rd Straight Day As "Second Wave" Hammers Globe: Live Updates
AstraZeneca beats expectations in Q2, while GSK struggles during pandemic
Johnson & Johnson Starts First Human Trials For Its Covid-19 Candidate
AMD Stock Price Up After Raising Guidance on Revenue Growth Expectations for 2020
Aviation Flu? It Will Take Years For Passenger Numbers To Fully Recover
China, Germany Suffer Alarming Jump In New COVID-19 Cases As "Second Wave" Spreads: Live Updates
AstraZeneca beats forecasts on strong drug sales, backs outlook
Quest Gets FDA Nod For Faster Covid-19 Testing; Analyst Flips To Buy Call
Moderna: Phase 3 Trial and Additional BARDA Funding Outweigh IP Issues, Says Top Analyst
Buy This Coronavirus Stock on Weakness, Says 5-Star Analyst
Snyder: We Are In The Process Of Completely Losing America
Roubini: Revisiting The White Swans Of 2020
Fed Reaction: Stimulus forever trade, but fiscal policy essential, Oil steady, Gold rally fizzles
Slowing down a ‘helper’ cell may someday make vaccines more effective for seniors
The Ugly Scramble
Russian COVID-19 vaccine approval imminent, source says
Moderna says COVID-19 vaccine pricing to ensure broad access
New survey finds large racial divide in concern over ability to pay for COVID-19 treatment